Live Quote · NASDAQLRMRHealthcare · Biotechnology

Larimar Therapeutics, Inc.

$4.08▼ 4.12%($-0.17)

MKT CAP $423.32MNEXT EARNINGS Nov 5, 2026

50%

Bullish

50%

Bullish

TickerSpark Score

56/100

▌ Mixed

80

Valuation

20

Profitability

15

Growth

84

Health

80

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LRMR research report →

Analyst Price Target

$8.00+96.3% vs. today

Range $5 – $11

Analyst RatingBuy

8 Buy0 Hold0 Sell

Price Chart

+7.82% · this period

52-Week Range37% of range

Low

$2.71

Current

$4.08

High

$6.42

Float & Shares

Free Float: 57.7%
Shares Outstanding: 103.88M
Float Shares: 59.94M

Institutional Ownership

99.7%

of shares held by institutions

138 13F filers

Insider ActivityLast quarter

1 Buys0 Sells

Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.

13F Holders · LRMR

Top institutional holders

Largest 13F positions, with quarter-over-quarter change.

Holder	Shares	Δ Quarter
Vanguard Group Inc	3.05M	▼ 41.62K
Hap Trading, LLC	262.78K	▲ 262.78K
Cubist Systematic Strategies, LLC	162.16K	▲ 162.16K
Two Sigma Advisers, LP	89.12K	▼ 163.25K
Cwm, LLC	64.13K	▲ 31.50K
Journey Strategic Wealth LLC	35.88K	▲ 47
Cherry Tree Wealth Management, LLC	15.26K	0
Point72 (Difc) Ltd	10.16K	▲ 10.16K
California State Teachers Retirement System	2.63K	▼ 361

ETF Exposure · LRMR

Held by 107 ETFs

Biggest fund positions in LRMR by dollar value.

VTI

0.0% wt$8.43M

IWM

0.0% wt$7.25M

FESM

0.1% wt$3.69M

VXF

0.0% wt$2.67M

IBB

0.0% wt$1.66M

VTWO

0.0% wt$1.43M

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

Date	Insider	Role	Type	Shares	Value
Jul 6, 26	Hamilton Thomas Edward	director	buy	50,000	$166.89K
May 19, 26	Flynn James E	director, 10 percent owner, other: * Director by Deputization	other	55,150	$183.65K
May 19, 26	LEFF JONATHAN S	director	other	55,150	$183.65K
May 19, 26	SHERMAN JEFFREY W	director	other	55,150	$183.65K
May 19, 26	Truitt Joseph	director	other	55,150	$183.65K
May 19, 26	THOMAS FRANK E	director	other	55,150	$183.65K
May 19, 26	Hamilton Thomas Edward	director	other	55,150	$183.65K
Feb 27, 26	Flynn James E	director, 10 percent owner, other: * Director by Deputization	buy	1,084,012	$5.42M
Feb 27, 26	Flynn James E	director, 10 percent owner, other: * Director by Deputization	buy	1,084,010	$5.42M
Feb 27, 26	Flynn James E	director, 10 percent owner, other: * Director by Deputization	buy	831,978	$4.16M

A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.

Larimar Therapeutics, Inc.

Price Chart

About the company

Get TickerSpark's AI analysis on LRMR

Similar companies

Top institutional holders

Held by 107 ETFs

Recent insider transactions

Our LRMR coverage

No research on LRMR yet